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Summary 
Inadequate haemostasis is one of the most important causes of morbidity and mortality following 
urological surgery. Despite the long term usage of coagulation, there is an ongoing development 
of new devices including, bipolar transurethral resection of the prostate (B-TURP) or new vessel 
sealing devices (VSD). A thorough understanding of the advantages and disadvantages of these 
new instruments can improve the operative experience for both urologist and patient. The 
optimal coagulation system should be small, efficient, easy to handle and with low heat spread. 
In this review we analysed different electrothermal coagulation systems and modern tissue 
sealing devices in urological applications with the aim to substantiate the advantages and 
disadvantages of each technique in terms of efficacy and safety.  
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Expert commentary 
Introduction 
Electrosurgery uses high-frequency electrosurgical energy, modified from standard electricity by 
an electrosurgical generator, to create a desired clinical effect.[1-2] A standard 60 Hz alternating 
electric current is unsafe for use in the body as it subjects the patient to the risk of 
neuromuscular stimulation and electrocution.[2] An electrosurgical generator is used to increase 
the frequency over 100’000 Hz to eliminate nerve and muscle stimulation and to render the 
energy safe.[2] Tissue effects that can be achieved with electrosurgery can be roughly divided 
into three basic groups: cutting, fulguration, and desiccation. Achieving these effects depend on 
the following factors: current density, time, electrode size, tissue conductivity, and type of current 
waveform.[1]  
Electrosurgical generators can apply energy in either a monopolar or bipolar fashion. Monopolar 
coagulation is the oldest method in which current is applied through a handheld active electrode 
and travels back to the generator through an inactive electrode attached to the patient (the 
grounding pad), so that the patient is part of the electrical circuit. In monopolar TURP, the target 
tissue is the prostate, where the majority of the energy gets transmitted and converted to heat, 
achieving the desired tissue effect or cutting and/or coagulation.[2] The tissue effect is 
determined by power setting (wattage), contact surface area of the wire loop, the type of radio 
frequency (RF) energy, duration of tissue contact, and tissue resistance (impedance).[2] 
Common to all electrocoagulative devices is a rise in tissue temperature during application of 
energy. In general, below 45°C, thermal damage to tissue is reversible. As tissue temperatures 
exceed 45°, the proteins in the tissue become denatured, losing their structural integrity. Above 
90°C, the liquid in the tissue evaporates, resulting in desiccation if the tissue is heated slowly or 
vaporization if the heat is delivered rapidly.[1] Once the tissue temperatures reach 200°C, the 
remaining solid components of the tissue are reduced to carbon.  
Despite the ongoing development of new devices like bipolar transurethral resection of the 
prostate (B-TURP), vaporisation of the prostate or new vessel sealing devices (VSD), potential 
pitfalls or complications also exist. A thorough understanding of the advantages and limitations 
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of these novel instruments can improve the operative experience for both urologist and patient. 
The optimal coagulation system should be small, efficient, easy surgical handling with a high 
burst pressure and low heat spread. Since many of these attributes are exclusive of each other, 
different application will require different instruments and settings.  
In this review we analysed different electrothermal coagulation devices and modern tissue 
sealing systems in urological applications with the aim to substantiate the advantages and 
disadvantages of each technique in terms of efficacy and safety.  
 
Materials and Methods 
Literature search strategy 
A literature review was performed from 1989 to 2010 using the US National Institutes of Health’s 
PubMed database. The reference lists of all selected papers were further reviewed for potentially 
relevant studies. Eligible studies were full papers written in English language reporting on at 
least one of the two primary outcomes of interest: efficacy and safety.  
Article selection 
Combinations of the following key words were used: monopolar, bipolar, vessel sealing devices, 
blood loss, operative time, prostatectomy, cystectomy, kidney surgery and urology. There were 
six randomized controlled trials[3-8] and one systematic review to evaluate the evidence based 
on randomized controlled trials (RCTs).[9] Six review articles were studied as full-text version.[1-
2,10-13] In addition, five comparative studies, ten animal studies and several case series with a 
total of more than 10’000 patients were analysed. Table 1 & 2 gives an overview of the 
electrothermal sealing systems in urological applications.  
 
Results 
Monopolar coagulation 
Monopolar electrocoagulation has proven to be less effective and safe.[14] This is because the 
physical characteristics of single radiofrequency (RF) energy with limited tissue effect.[15] 
Electrosurgical delivery of energy using monopolar instruments can be enhanced by 
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incorporating a stream of argon gas to improve the surgical effectiveness in maintaining 
hemostasis over larger surfaces.[1] The ultimate dual function (cutting and coagulation) rests in 
having two independent RF energies capable of exerting the desired hemostatic tissue 
effect.[15] For procedures performed in a liquid medium such as TURP, the liquid medium needs 
to be nonconductive in order to prevent energy dispersing away from the target organ. Low-
electrolyte hypo-osmolar irrigation fluids such as glycine solutions are used in monopolar TURP. 
However, such solutions subject the patient to the risk of dilutional hyponatremia and TUR 
syndrome.[2]  
 
Bipolar coagulation 
Bipolar delivery of energy does not require a dispersive return electrode pad because both the 
active electrode and the return electrode are integrated into the energy delivery forceps with the 
target tissue between. Bipolar electrosurgical instruments have evolved from being used in the 
coagulation of tissue to the creation of complete fusion of the intimal layers of vascular 
structures. Further, bipolar energy is also used to improve the simultaneous cutting and 
coagulation during surgeries of highly vascularised tissues. The main advances over the last 
year were made in the use of biopolar devices for endourology and the application of biopolar 
energy to Vessel Sealing Devices (VSD).  
One randomized controlled trial assessed the efficacy and safety of the monopolar transurethral 
resection of the prostate (TURP) and compared it with the bipolar electrocautery and physiologic 
saline.[4] In their study, the authors found no difference in resection time, haemoglobin fall or 
resected tissue. However, there was a significant lower serum Na of -4.6mEq/L in the monopolar 
electrocautery group when compared to bipolar electrocautery (-1.2mEq/L, p < 0.001). 
Mandhani and coworkers monitored the temperature with a needle electrode in 15 cases of 
athermal nerve sparing and 10 cases of non-nerve sparing robotic radical prostatectomy 
(RRP).[16] In this study, the mean time to return to baseline temperature was 3 seconds more 
with bipolar than monopolar and the authors concluded that bipolar cautery may not be safer 
than monopolar because of a greater rise in temperature of surround tissue within 1cm of its 
use.[16] Clearly, monopolar devices continue to play a defined role in modern surgery. 
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Endourology 
The introduction of bipolar technology in TURP seems to be a promising technical modification 
offering possible benefits both for the patient[17] and for training purposes.[18] It shares similar 
clinical efficacy with monopolar transurethral resection of the prostate, durable in time with low 
long-term complications rates. It has minimized bleeding risks and eliminated transurethral 
resection syndrome by using normal saline as irrigation fluid. In bipolar TURP, the two poles 
(active and return) are incorporated into the electrode design.[2] Mamoulakis et al. evaluated the 
evidence based on 16 randomized controlled trials (RCTs) that compare bipolar-TURP with 
monopolar transurethral resection of the prostate (M-TURP) in patients with benign prostatic 
obstruction (BPO) and conducted a quantitative meta-analysis in an attempt to provide 
conclusions based on level 1a evidence.[9] Considering the two main limitations, low trial quality 
and the relatively limited follow-up, this systematic review provides the strongest available 
evidence to date showing that no clinically relevant differences in short-term efficacy exist 
between the two techniques. Furthermore, no differences were evident regarding operation time 
and rates of adverse events such as transfusions and retention after catheter removal.  
Since january 2008, TURis plasma vaporisation offers a minimally invasive alternative. Due to 
the TURis plasma vaporisation electrode development, and its addition to the current selection 
of TURis electrodes (large loop, band electrode and TUEB (Transurethral Enucleation Bipolar) 
electrode for enucleation), the method combines the advantages of vaporisation with the 
benefits of bipolar resection. The electrical current mainly flows directly from the electrode loop 
to the electrode tube as the electrical impedance of the surrounding saline solution is 
significantly lower compared to the human tissue (1:10). Thus the current flow is locally limited 
and, compared to the monopolar technique, the leakage current is reduced by 70%.  
In a randomized controlled trial, Fragerström et al. randomized 202 consecutive patients to 
undergo TURP using either a bipolar system or a monopolar system. The authors could show 
that bipolar TURP using the TURis system was performed with the same speed as monopolar 
TURP but causes 34% less bleeding. Bipolar TURP also required fewer erythrocyte transfusions 
than the conventional monopolar technique.[6] Puppo et al. evaluated the safety and outcome of 
TURis in 1000 cases with a median follow-up of 12 months.[19] None of the patients 
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experienced a TUR syndrome while the TURis device after a median resection time of 42 
minutes was not associated with a greater incidence of urethral strictures (2.7%) compared to 
data obtained with monopolar devices. The authors observed that in the TURis case there is a 
dispersion flow in optimal conditions of about 6–7mA and in abnormal conditions (multiuse) of 
about 50 mA, and hence 20/25 times below the limit in normal conditions and 3 times below in 
abnormal conditions (reusing the same loop). Accordingly, they decided to use a new loop for 
each resection.[19] Ho and coworkers presented their preliminary results on clinical efficacy and 
safety with the TURis system in 45 patients with clinically significant BPH. Their study indicated 
that TURis is a safe and efficacious treatment for BPH at 1 year.[20]  The same authors 
confirmed their results later in a prospective randomized study with a larger cohort of 100 
patients. Mean resection time and mean weight of resected prostate tissue were comparable for 
both groups. Declines in the mean postoperative serum Na+ for TURis and monopolar TURP 
groups were 3.2 and 10.7 mmol/l, respectively (p<0.01). However, there was no statistical 
difference in the decline in postoperative Hb between the two groups. Urethral strictures were 
observed in three cases of TURis and one patient in the monopolar group. The IPSS 
(International Prostate Symptom Score) and Qmax. improvements were comparable between 
the two groups at 12 months follow-up.[5] 
The evidence derived from randomized clinical trials does not show a statistically significant 
difference of urethral strictures when bipolar energy is compared with monopolar.[11] This has 
been confirmed in a clinical review of bipolar TURP.[2] Similar efficacy between bipolar TURP 
and monopolar TURP has been shown with a significant lower adverse events with bipolar 
TURP. The rates of erectile and ejaculatory dysfunctions were similar with both systems at 
approximately 14% and 50%, respectively.[2] In another study, Ko and coworkers compared the 
thermal and histopathological effects of two commercially available bipolar systems ((Gyrus 
PlasmaKinetic and Vista, both from Gyrus-ACMI Corporation, Maple Grove, MN, USA) and 
conventional monopolar transurethral resection (Force TM2, Valleylab, Boulder, CO, USA) of the 
prostate (TURP) in a canine model. In their study, bipolar TURP generated significantly less heat 
and histopathological evidence of thermal damage compared with monopolar TURP.[21] 
 
 9
Vessel Sealing Devices (VSD) 
With recent improvements in computing technology being integrated into electrosurgical 
generators, the use of sophisticated closed-loop feedback control algorithms has created the 
ability to fuse vascular structures up to 7 mm in diameter. This allows the surgeon to create an 
“autologous clip” to achieve hemostasis without suture, staples, or traditional clips. These 
“vessel sealing” devices were first introduced in 1998.   
LigaSure is a bipolar electrosurgical device designed to deliver high current and very low voltage 
to tissue. It monitors tissue impedance between the jaws of the instrument and continuously 
adjusts the delivery of energy. It seals vessels by applying high, uniform mechanical 
compression while monitoring and adjusting energy delivery to the tissue. Because this product 
relies heavily on the collagen and elastin content of vessels to achieve hemostasis, it works well 
for arteries and veins but inconsistently in tissues where the blood supply is delivered 
predominantly by capillaries, which have a low collagen content.[22] Three articles reported a 
significantly reduced blood loss and operative time using the LigaSure device.[3,23-24] 
However, a potential drawback of vessel sealing devices are costs and the possibility of tissue 
injury leading to necrosis and perforation.[25-26] In a prospective randomized trial comparing 
thermal and mechanical endoscopic methods to obtain hemostasis, hemoclips has found to be 
superior to heat probe in preventing early recurrent bleeding ulcers.[8] 
EnSeal(®) (Ethicon, Cincinnati, OH) has been demonstrated to limit collateral thermal tissue 
damage to <1.0 mm. It has been shown that EnSeal works effectively and adjacent thermal 
tissue damage is significantly minimized when submerged in cold saline irrigation during 
hemostasis of the prostatic vascular pedicles (PVP).[27]  
The Gyrus Plasma Trissector (GPT), (Gyrus Group PLC, Gyrus International, Ltd.UK) uses high-
powered pulsed bipolar energy to produce a plasmakinetic field around the working elements 
and is designed to operate at temperatures that allow effective tissue dissection but result in 
minimal collateral damage and adherence to tissue.[28]  
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Open surgery 
Daskalopoulos et al. evaluated the use of an electrothermal bipolar coagulator (LigaSure device) 
in major urologic procedures, including open radical prostatectomies and radical 
cystectomies.[23] 58 patients aged 56–74 years (mean: 65 years) underwent open radical 
prostatectomy and open radical cystectomy performed by the same surgeon, employing either 
conventional ligation in the control group (radical prostatectomy, n = 15; radical cystectomy n = 
9) or the LigaSure device in the study group (radical prostatectomy, n = 24; radical cystectomy n 
= 10) to ensure blood vessel patency. Effectiveness and postoperative outcomes were 
evaluated. The mean operation time was significantly shorter in the LigaSure group compared to 
the control group for both the prostatectomy (125 minutes vs. 144 minutes, p < 0.001) and the 
cystectomy procedures (253 minutes vs. 281 minutes, p < 0.001). In addition, the mean 
intraoperative blood loss was significantly lower in the LigaSure group compared to the control 
group for both prostatectomy (569 ml vs. 685 ml, p = 0.04) and cystectomy procedures (637 ml 
vs. 744 ml, p = 0.02). There were no serious intraoperative or postoperative complications 
related to the use of the device.  
Futher, Sengupta et al. evaluated the application of LigaSure in open urological surgery.[24] The 
VSD device was used in 32 consecutive open surgical cases, including 25 radical 
prostatectomies, five radical nephrectomies, one partial nephrectomy and one nephro-
ureterectomy. The LigaSure device was used in pelvic lymphatics and prostatic, adrenal, 
gonadal and aberrant obturator vessels, as well as vessels associated with the ureter, vasa, 
seminal vesicles, peri-renal fat, peritoneum and peri-adrenal tissue. No additional clips or 
sutures were required to secure any vessels < 7mm in diameter. The authors reported a 
significant reduction in intraoperative blood loss and operation time with LigaSure in open radical 
prostatectomy.[24] Postoperatively, there were no instances of haemorrhage, lymph leakage or 
lymphocele formation. The authors concluded that the VSD is safe and easy to use in major 
urological procedures. They also reported that some structures (e.g. the vas and the seminal 
vesicle) are difficult to control using clips because of their friability and poor access. The 
LigaSure device allowed them to seal these structures with much greater ease. Given the limited 
lateral thermal damage, they successfully used the device next to the iliac veins and the inferior 
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vena cava. The device performed well even in the presence of blood or urine, as distinct from 
conventional diathermy.  
Kennedy et al. used the LigaSure device on the spermatic cord structures and vas while 
performing an unilateral inguinal orchiectomy.[29] Once the spermatic cord was identified and 
dissected free from the vas, it was divided. The spermatic cord and the vas were successfully 
ligated using the LigaSure Max handset.[29] There are also reports of laparoscopic varicocele 
ligation with the LigaSure in male children and adolescents.[30] In a well-designed open study, 
Hruby and coworkers assessed the vessel sealing capabilities and the peripheral energy spread 
associated with currently available energy based surgical instruments.[31] They found a high 
burst pressure with the LigaSure (LS) and a rapid sealing time. The LS device was compared to 
two ultrasonic devices and a prototype plasmakinetic trissector and was found to be the overall 
best device. The best sealing was seen with the LS device and the poorest with the Harmonic 
Scalpel.[31]  
The reusable BiClamp® bipolar coagulation forceps has been available for open surgery 
procedures since 2002. Richter and coworkers studied the efficacy of the reusable BiClamp® 
versus the standard disposable LigaSure bipolar vessel sealing device using a porcine 
model.[32] In their study, the burst pressures of the BiClamp®-sealed arteries (842 ± 117mmHg) 
did not differ from that of arteries sealed with LigaSure (856 ± 102mmHg), but were significantly 
higher than the burst pressures of veins (155 ± 26 and 216 ± 71mmHg, respectively) (p < 0.05). 
Independent of the sealing device used, thermal spread was found increased in veins compared 
to arteries. The authors concluded that the BiClamp® device is as appropriate as the LigaSure 
instrument to successfully ligate 2-7mm arteries and veins, demonstrating supraphysiological 
bursting strengths and adequate luminal fusion healing. However, the BiClamp® required an 
extra 2 to 3 seconds to seal arteries and veins. Thermal spread was increased along veins 
compared to arteries. However, the precise distance of spread was not reported. 
 
Laparoscopy 
Leonardo et al. compared the effectiveness of the LigaSure Atlas system with earlier methods in 
30 patients affected by clinically localized renal-cell carcinoma who underwent transperitoneal 
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laparoscopic radical nephrectomy with a three-trocar technique. They found no conversion in 
either group. Statistically significant differences were observed between conventional and 
LigaSure nephrectomy regarding mean intraoperative blood loss (485 v 100ml, respectively; p < 
0.005) and mean operative time (164 v 68 minutes, respectively; p < 0.05). No statistical 
difference was observed in the postoperative discharge time[3] and no evidence of collateral 
tissue injury or injuries to the intestinal tract were found.  
Metzelder and coworkers evaluated the feasibility of LigaSure in laparoscopic transperitoneal 
heminephroureterectomy in seven consecutive pediatric patients.[33] The authors used the “all-
in-one” function of the LigaSure vessel sealing system (dissecting, coagulating, and cutting). For 
comparison, the data of seven consecutive patients who had undergone open retroperitoneal 
heminephroureterectomy were analyzed. The authors concluded that the feasibility of 
transperitoneal laparoscopic heminephroureterctomy (LH) using LigaSure was excellent. There 
were no intraoperative events or complications. However, the operative time for LH was higher 
(144 ± 18.4min.) compared to open heminephroureterectomy (110 ± 11.7min.), although the 
difference did not reach significance (p = 0.5). One randomized trial assessed the effectiveness 
and feasibility of the Ligasure system in a group of patients affected by renal-cell carcinoma and 
who underwent laparoscopic radical nephrectomy.[3] The authors concluded that the Ligasure 
vessel-sealing system seems to produce a consistent, reliable, permanent seal of vein, arteries, 
and tissue bundles by fusing the collagen in vessel walls and appears to be effective in 
advanced laparoscopic procedures. In one article, the authors reported of “meticulous 
hemostasis” using the 10-mm LigaSure devise for laparoscopic ureterolysis and omental 
wraping for the treatment of idiopathic retroperitoneal fibrosis in six patients.[34] 
 
Ex vivo experimental model  
A study by Kennedy at al. compared the LigaSure Vessel Sealing System with ultrasonic 
coagulation, bipolar coagulation, surgical clips and sutures.[35] In this study, 210 freshly excised 
porcine renal arteries ranging from 3 - 7 mm in diameter were occluded using the LigaSure VSD 
System, ultrasonic coagulator, bipolar forceps, mechanical clips or standard silk ties. The 
vessels were then cannulated and pressurized with saline using a syringe pump until the 
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occlusion burst. Pressure was recorded when the occluded or normal vessel wall burst, or when 
the measurement system reached its maximum pressure of 900 mmHg. The study results 
demonstrated that the LigaSure VSD System creates seals that are stronger than other energy-
based ligation methods (ultrasonic coagulation and standard bipolar coagulation), and 
comparable in strength to mechanical ligation techniques such as clips and sutures.[36] Seals 
created by the LigaSure System were shown to withstand a minimum of three times normal 
systolic pressure.[29]  
Lamberton et al. compared two bipolar sealing devices (LigaSure V and Gyrus PK), an 
ultrasonic device (Harmonic Scalpel ACE) and a novel device using nanotechnology (EnSeal 
PTC) in a large animal model to seal 5 mm bovine arteries.[37] The EnSeal PTC uses bipolar 
electrical energy but employs a nanotechnology feedback mechanism to reduce thermal spread 
by changing the energy required for sealing in response to tissue characteristics. The ultrasonic 
device demonstrated the least thermal spread, whereas the LigaSure V and Gyrus PK had the 
fastest sealing times (10.0 secs and 11.1secs, respectively). The ultrasonic device was the 
slowest and had variable burst pressures. The highest burst pressure value was found with the 
LigaSure V device (385mmHg). The lowest Tmax at 2mm laterally was found with the Harmonic 
Scalpel (49.9°C). In comparing the objective amount of particulates produced during vessel 
sealing the Harmonic Scalpel had the least amount of smoke produced while the Gyrus PK 
produced the greatest amount of smoke. All devices tested resulted in temperatures 2 mm away 
from tissue that were greater than 40 degrees C and hence should be used with caution next to 
sensitive structures like the neurovascular bundle. However, potential limitations with this model 
include vessels without blood, an ex vivo experimental model and missing delayed failure. 
 
Radiofrequency ablation (RFA) 
The fundamental concept of RFA is transfer of alternating monopolar radiofrequency electrical 
current through needle electrodes into target tissue that results in ionic agitation, heating, and 
eventual desiccation with subsequent coagulative necrosis.[10] Radiofrequency energy can be 
applied using needles placed directly into tissues (dry RFA) or with ionic solutions perfused into 
tissues to act as a coupler (wet RFA).[38] Experimental and clinical experience, however, 
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suggests that wet and dry RFA modalities are equally effective in causing cell death.[10] 
Different RFA instruments have already been used for laparoscopic partial nephrectomy and 
were proven to have good hemostatic potential.[39-40] Richstone et al. described the use of a 
novel bipolar radiofrequency (RF) system for the destruction of prostate tissue in an ex vivo 
model.[41] In their study, the bipolar RFA is capable of producing lesions with precise margins. 
Spread of heat was limited, evidenced histologically and by significant temperature drop off.  
 
Five-year view 
The increase in the number of day-case procedures performed and the rapid expansion of 
minimal access surgery have highlighted the importance of ensuring both meticulous surgical 
technique and haemostasis. The possibility of contaminated blood products and the hazards of 
blood transfusion are further stimuli for the avoidance of unnecessary blood transfusion. 
Therefore, urologists have to make the right choice to determine the optimal thermal coagulation 
method for each surgery. 
 
Endourology 
For the treatment of benign prostatic hyperplasia, transurethral monopolar resection of prostate 
(TURP) is the most effective surgical modality and gold standard.[42] However, transurethral 
resection (TUR) syndrome is an uncommon but potentially life-threatening complication of 
monopolar TURP in which glycine solution is used for irrigation.[43] Reich et al.’s prospective 
multicenter study on 10’654 BPH patients treated with TURP suggests a decrease in mortality 
(0.1%) but morbidity, although reduced, continues to be high (11.1%). B-TURP is preferable due 
to its more favourable profile, defined by the clinically relevant differences detected regarding 
complications such as TUR syndrome and clot retention. TURP using the TURis is a safe and 
efficacious treatment for BPH at 1 year with comparable resection time, mean weight of resected 
prostate tissue and lower morbidity. Also, bipolar TURP may prevent postoperative erectile 
dysfunction through limitation of tissue heating and extra prostatic current. In addition, 
withdrawal of acetylsalicylic acid (ASA), clopidogrel and anticoagulation prior to B-TURP is often 
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not necessary allowing these devices to be used in the growing elderly population with cardiac 
stents. However, data on follow-up of > 12 months are scarce for B-TURP, precluding long-term 
efficacy evaluation. A double-blind randomized trial that compares B-TURP with M-TURP for this 
complication is needed.  
 
Open surgery 
A wide variety of electrocoagulation devices have been used in open abdominal urologic 
surgery. However, some studies showed that the use of cautery devices in nerve sparing radical 
prostatectomy (nsRPE) is followed by a higher rate of erectile dysfunction.[44-45] On the other 
hand lower blood transfusion rates for nsRPE were reported when modern vessel sealing 
devices were used.[46] Modifications to reduce the adverse events of electrocoagulation may 
include sharp dissection in conjunction with bulldog clamps on the pedicles or release of 
neurovascular bundles without the use of electrocautery.[45] In addition, our findings suggested 
that the use of modern vessel-sealing devices for nerve-sparing radical prostatectomy is 
basically feasible and safe if a distance of 2.5 mm to the nerve is respected. Furthermore, we 
recommend protecting the nerve-vessel bundle by placing a clamp laterally to the device.[47] 
Bipolar cautery may not be safer than monopolar, which might be explained by the interaction of 
electric current with the biological tissue.[16] Also, lowering tissue temperature with irrigation 
was proven to be beneficial in reducing the collateral damage of the heat.[48] In tissues >1cm 
from cautery use, it has been shown that monopolar current causes a significantly higher 
temperature change compared with bipolar current but temperature elevation however are not 
sufficient to cause irreparable tissue damage with either current.[16] However, further studies 
are needed to fully investigate the pathologic damage associated with increase temperature due 
to electrocoagulation in the near future.  
Recently, we investigated the lateral thermal spread and the corresponding injury caused by 
vessel sealing devices (LigaSure Impact™ and LigaSure™ Axs) with regard to radical 
prostatectomies. To evaluate the precise lateral temperature spread along the musculofascial 
tissues, we used an infrared camera, continuous temperature measurement, and histology in an 
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in vitro model. We demonstrated that both vessel-sealing devices have a significant thermal 
spread of 2.5 mm (Fig. 1).  
LigaSure in open radical prostatectomy and open radical cystectomy are safe, and significantly 
decrease the blood loss, when compared to the conventional ligation method. However, daily 
clinical routine use of the disposable device causes considerable costs and has to be considered 
in the future. In this regard, the BiClamp® bipolar coagulation forceps as a reusable system 
seems to be a cost-effective and superior tool with regard to intraoperative blood loss, operating 
time and postoperative pain compared with conventional clamping and suture ligation.  
 
Laparoscopy 
The Ligasure vessel-sealing system seems to produce a consistent, reliable, permanent seal of 
veins, arteries, and tissue bundles by fusing the collagen in vessel walls. By reducing sutures 
and the number of instrument exchanges in the operating theatre, the Ligasure decreases 
operating time and blood loss. This new energy-based vessel-ligation device appears to be 
effective in advanced laparoscopic procedures.  
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Key issues 
 Inadequate haemostasis is one of the most important causes of morbidity and 
mortality following urological surgery 
 Electrothermal devices are an effective tool to reduce blood loss and save 
time in surgery  
 Despite the long term usage of coagulation in urology, there is an ongoing 
development of new devices 
 For all urologic surgeries multiple electrothermal devices can be used safely, if 
the surgeon is aware of their limitations 
 Well-designed multicentric randomized controlled trials (RCTs) with long-term 
follow-up and cost analysis are still needed to define the most suitable 
electrothermal device for each urologic procedure 
 Bipolar transurethral resection (B-TUR) of the prostate (TURP) is preferable 
due to a more favourable safety profile (lower TUR syndrome) 
 Data on follow-up of > 12 months are scarce for B-TURP, precluding long-
term efficacy evaluation 
 Data on TUR in saline (TURis) are not yet mature to permit safe conclusions 
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Figure 1 – Lateral thermal spread in vitro 
 
 
 
 
 
 
 
 
 
 
 
 
 
This figure shows the effect of different electrothermal modalities on the temperature of 
adjacent tissues in vitro. A) Vessel Sealing Device (LigaSure LS1500C, at completion of 
sealing process), B) Monopolar (Hot Shears, 60W 2 Sec) and C) Bipolar (Maryland 
Forceps, 60W 2 Sec). Temperature above 45 OC are displayed in white.  
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Tables 
Table 1 - Overview of the different electrothermal sealing systems in human clinical studies  
 
Reference  n  Electrothermal sealing system  Blood loss   Operative time Thermal spread Burst pressure   Notes 
Sengupta et al.[24] 32  LigaSure in open urological procedures vs. Significant lower  Significant shorter      Small sample size 
   control group             No randomization  
Daskalopoulos et al.[23] 58  LigaSure in open prostatectomy and cystectomy Significant lower  Significant shorter      Small sample size 
    vs. conventional ligation             No randomization 
Mamoulakis et al.[9] meta analysis B-TURP vs. M-TURP   no difference   no difference       limited follow-up (<1year),  
                                                                    low trial quality   
Leonardo et al.[3] 30  LigaSure Atlas in laparoscopic nephrectomy Significant lower  Significant shorter      Small sample size 
    vs. monopolar electrocautery and shears and  
standard clips 
Ho et al.[5]               100  M-TURP vs. TURIS   no difference   no difference       larger follow-up and larger number    
                   of patients are needed   
Issa et al.[49] 1802  M-TURP vs. PK B-TURP   no difference   no difference       lower complication rate with TURIS 
Simone et al.[34] 6  10-mm LigaSure atlas in laparoscopic ureterolysis meticulous hemostasis  time saving       Midterm results 
                  Small sample size 
Smaldone et al.[50] case report   EnSeal Tissue Sealing and Hemostasis System blood loss was minimal         Case report 
    In laparoscopic nephrectomy 
Urena et al.[51] 10  Monopolar radio frequency device (TissueLink DS  provides adequate hemostasis   Scant tissue charring    Retrospective study 
    dissecting sealer) in laparoscopic partial nephrectomy          Small sample size 
                                                                                     without clamping the renal vasculature             
Phillips et al.[52] 40  5mm LigaSure vs. Harmonic Scalpel vs. cold excision     No effect on soft tissue margin   Increased artifact using  
    in NSS               ultrasonic shears 
Higher positive margin rate 
without vessel clamping 
Metzelder et al.37 7  LigaSure in laparoscopic transperitoneal no intraoperative complications Mean operative time       Small sample size 
    Heminephroureterectomy in children     longer than open       No RCT 
           heminphroureterectomy 
Mamoulakis et al.[9] 1406  Bipolar vs. Monopolar TURP  No difference in transfusion rate No meta-analysis could be performed  
Ilbeigi et al.[53]  32 TissueLinke device (radiofrequency energy  Significant lower  No significance Charring up to 2mm Seals effectively arteries <3mm Small sample size 
                                             coupled with saline) vs. needlepoint electrocautery   
 
LND = lymph node dissection, NSS = Nephron sparing surgery, LPN = laparoscopic partial nephrectomy, BL = blood loss, RCT = randomized controlled trial, M-TURP = Monopolar transurethral resection of prostate, B-TURP = Bipolar transurethral resection of prostate 
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Table 2 - Overview of the different devices 
 
Device    Primary usage   Safe at what distance to nerves  weakness    best use 
LigaSure  Arteries & veins < 7mm   Tmax. at 2mm laterally 55.5°C  capillaries    radical prostatectomy, nephrectomy and cystectomy,  
                           arteries and veins < 7mm 
Gyrus PlasmaKinetic bipolar device  Laparoscopic nephrectomy  Thermal spread 3.5mm            
Harmonic Scalpel ACE   Arteries < 5mm    Tmax. at 2mm laterally 49.9°  low burst pressure (204Hg)   
TissueLinke device   Arteries < 3mm   Charring up to 2mm 
EnSeal PTC    Arteries < 5mm   Tmax. at 2mm laterally 55.5°  lo burst pressure (255Hg)        
KTP laser    TUR-P, LPN    no clean resection margins      BPO 
Habib Sealer    LPN    no clean resection margins 
SonoSurg    LPN        higher BL 
Bipolar TUR-P   TUR-P            BPO. Minimized bleeding risk in patients on aspirin/clopidogrel 
Monopolar TUR-P   TUR-P        TUR syndrome   BPO 
TURis    TUR-P            BPO. Combines the advantages of vaporisation with the  
                  Benefits of bipolar resection 
BiClamp® bipolar coagulation forceps  Ligate 2-7mm arteries and veins      thermal spread increased in veins  Ligate 2-7mm arteries and veins 
             extra 2 to 3 seconds needed to seal arteries and veins 
 
BL = blood loss, LPN = Laparoscopic partial nephrectomy, BPO = benign prostatic obstruction, TURis = transurethral resection in saline, RITA = radiofrequency interstitial tumor ablation   
 
